REZUROCK

Product Overview

About REZUROCK

REZUROCK is a prescription medication containing the active ingredient Belumosudil (Belumosudil Mesylate). It is used to treat chronic graft-versus-host disease (cGVHD) in adult patients who have failed at least two prior lines of systemic therapy.

Key Benefits & Uses

• Treatment of chronic graft-versus-host disease (cGVHD) in adult patients who have failed at least two prior lines of systemic therapy.
• May help manage symptoms of cGVHD, such as skin rash, joint pain, and lung problems.
• Prescribed for patients who have not responded to other treatments for cGVHD.

Active Ingredient & Action

Belumosudil (Belumosudil Mesylate) is a small molecule inhibitor of the Rho-associated coiled-coil containing protein kinase (ROCK) pathway. By inhibiting this pathway, Belumosudil helps to reduce inflammation and modulate the immune response, which can help manage symptoms of cGVHD.

Important Notes

REZUROCK is a prescription medication and should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully. Common side effects of REZUROCK may include headache, diarrhea, and fatigue. Patients should inform their doctor about any medical history, including liver or kidney disease, before starting treatment with REZUROCK.